Nationwide study on multimorbidity prevalence: 7.64 million primary healthcare users in Portugal with multiple chronic conditions

IF 3.2 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Public Health Pub Date : 2025-03-01 Epub Date: 2025-01-22 DOI:10.1016/j.puhe.2025.01.005

Filipe Prazeres

{"title":"Nationwide study on multimorbidity prevalence: 7.64 million primary healthcare users in Portugal with multiple chronic conditions","authors":"Filipe Prazeres","doi":"10.1016/j.puhe.2025.01.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The goal of this study was to explore the prevalence of multimorbidity, its geographic variation, and changes from 2022 to 2024 in Portugal.</div></div><div><h3>Study design</h3><div>Information regarding the chronic health conditions active in the primary healthcare patients' health problems lists on the electronic health records are derived from the digital platform Identity Card of Primary Healthcare (Bilhete de Identidade dos Cuidados de Saúde Primários, BI CSP) data for the period of 2022 and 2024.</div></div><div><h3>Methods</h3><div>BI CSP nationwide data from May 2024 of the 10,366,861 registered users in Portuguese primary healthcare were used to determine the prevalence of multimorbidity (presence of 2 or more chronic health conditions) and analize differences to 2022.</div></div><div><h3>Results</h3><div>By May 2024, 73.7 % of the population (7.64 million out of 10.37 million registered users in primary healthcare) were living with multimorbidity, indicating a 4.7 % increase from 2022. The most common chronic conditions in 2024 included lipid disorders, hypertension, obesity, and tobacco abuse. Regionally, multimorbidity exceeded 65 % in all zones, with the North (78.9 %) and Alentejo (78.3 %) regions having the highest rates. The prevalence increased across all regions, with the North region showing the smallest increase from 2022 to 2024.</div></div><div><h3>Conclusions</h3><div>The prevalence of multimorbidity in Portugal is increasingly high across all the regions considered. Additional studies will be helpful in determining the extent to which the now-reported high prevalence of multimorbidity will impact the healthcare system in Portugal.</div></div>","PeriodicalId":49651,"journal":{"name":"Public Health","volume":"240 ","pages":"Pages 18-20"},"PeriodicalIF":3.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0033350625000253","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

The goal of this study was to explore the prevalence of multimorbidity, its geographic variation, and changes from 2022 to 2024 in Portugal.

Study design

Information regarding the chronic health conditions active in the primary healthcare patients' health problems lists on the electronic health records are derived from the digital platform Identity Card of Primary Healthcare (Bilhete de Identidade dos Cuidados de Saúde Primários, BI CSP) data for the period of 2022 and 2024.

Methods

BI CSP nationwide data from May 2024 of the 10,366,861 registered users in Portuguese primary healthcare were used to determine the prevalence of multimorbidity (presence of 2 or more chronic health conditions) and analize differences to 2022.

Results

By May 2024, 73.7 % of the population (7.64 million out of 10.37 million registered users in primary healthcare) were living with multimorbidity, indicating a 4.7 % increase from 2022. The most common chronic conditions in 2024 included lipid disorders, hypertension, obesity, and tobacco abuse. Regionally, multimorbidity exceeded 65 % in all zones, with the North (78.9 %) and Alentejo (78.3 %) regions having the highest rates. The prevalence increased across all regions, with the North region showing the smallest increase from 2022 to 2024.

Conclusions

The prevalence of multimorbidity in Portugal is increasingly high across all the regions considered. Additional studies will be helpful in determining the extent to which the now-reported high prevalence of multimorbidity will impact the healthcare system in Portugal.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

全国性多病流行率研究：葡萄牙764万患有多种慢性疾病的初级保健使用者。

目的：本研究的目的是探讨2022年至2024年葡萄牙多病的患病率、地理差异和变化。研究设计：电子健康记录中初级保健患者健康问题列表中活跃的慢性健康状况信息来自初级保健数字平台身份证（Bilhete de Identidade dos Cuidados de Saúde Primários, BI CSP） 2022年和2024年期间的数据。方法：利用2024年5月葡萄牙初级卫生保健机构10,366,861名注册用户的BI CSP全国数据，确定多病（存在两种或两种以上慢性健康状况）的患病率，并分析与2022年的差异。结果：到2024年5月，73.7%的人口（1037万初级卫生保健注册用户中有764万人）患有多种疾病，比2022年增加了4.7%。2024年最常见的慢性疾病包括脂质紊乱、高血压、肥胖和吸烟。从区域来看，所有地区的多重发病率都超过65%，其中北部（78.9%）和阿连特茹（78.3%）地区的发病率最高。所有地区的患病率都有所上升，从2022年到2024年，北部地区的增幅最小。结论：葡萄牙的多病患病率在所有考虑的地区都越来越高。进一步的研究将有助于确定现在报道的多病高患病率将影响葡萄牙医疗保健系统的程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health 医学-公共卫生、环境卫生与职业卫生

CiteScore

7.60

自引率

0.00%

发文量

280

审稿时长

37 days

期刊介绍： Public Health is an international, multidisciplinary peer-reviewed journal. It publishes original papers, reviews and short reports on all aspects of the science, philosophy, and practice of public health.